Recent studies have demonstrated the efficacy of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in managing neuropathic pain, commonly linked to diabetic neuropathy and various chronic pain disorders. The gene discussed is GLP1R; the disease is diabetic neuropathy.